INR 1030.55
(-0.07%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 6.66 Billion INR | 10.33% |
2022 | 6.04 Billion INR | 17.03% |
2021 | 5.16 Billion INR | 0.55% |
2020 | 5.13 Billion INR | 24.38% |
2019 | 4.12 Billion INR | 2.98% |
2018 | 4 Billion INR | 1054750.0% |
2017 | 380 Thousand INR | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 6.89 Billion INR | 0.0% |
2024 Q1 | - INR | -100.0% |
2023 Q3 | - INR | -100.0% |
2023 FY | 6.66 Billion INR | 10.33% |
2023 Q2 | 6.69 Billion INR | 0.0% |
2023 Q4 | 6.66 Billion INR | 0.0% |
2023 Q1 | - INR | -100.0% |
2022 Q4 | 6.04 Billion INR | 0.0% |
2022 FY | 6.04 Billion INR | 17.03% |
2022 Q3 | - INR | -100.0% |
2022 Q2 | 6.36 Billion INR | 0.0% |
2022 Q1 | - INR | -100.0% |
2021 Q2 | 5.05 Billion INR | 0.0% |
2021 FY | 5.16 Billion INR | 0.55% |
2021 Q4 | 5.16 Billion INR | 0.0% |
2021 Q1 | - INR | -100.0% |
2021 Q3 | - INR | -100.0% |
2020 Q1 | - INR | 0.0% |
2020 Q4 | 5.13 Billion INR | 1.04% |
2020 Q3 | 5.08 Billion INR | 0.0% |
2020 FY | 5.13 Billion INR | 24.38% |
2019 FY | 4.12 Billion INR | 2.98% |
2018 FY | 4 Billion INR | 1054750.0% |
2017 FY | 380 Thousand INR | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Sigachi Industries Limited | 707.2 Million INR | -842.568% |
Ind-Swift Limited | 640.91 Million INR | -940.061% |
Bajaj HealthCare Limited | 1.44 Billion INR | -362.788% |
Sakar Healthcare Limited | 277.32 Million INR | -2303.663% |
Aurobindo Pharma Limited | 98.08 Billion INR | 93.204% |
Innova Captab Limited | 1.44 Billion INR | -362.859% |
Divi's Laboratories Limited | 31.84 Billion INR | 79.064% |
AstraZeneca Pharma India Limited | 2.27 Billion INR | -192.516% |
Morepen Laboratories Limited | 2.48 Billion INR | -168.144% |
Mankind Pharma Limited | 15.53 Billion INR | 57.09% |
Sequent Scientific Limited | 3.46 Billion INR | -92.527% |
Wanbury Limited | 360.23 Million INR | -1750.449% |
Laurus Labs Limited | 18.45 Billion INR | 63.878% |
Nectar Lifesciences Limited | 7.09 Billion INR | 6.002% |
Alembic Limited | 113.4 Million INR | -5778.228% |
Hikal Limited | 3.03 Billion INR | -119.476% |
Alembic Pharmaceuticals Limited | 16.43 Billion INR | 59.442% |
Neuland Laboratories Limited | 3.5 Billion INR | -90.225% |
J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | -32.652% |
Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 73.475% |
IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | -56.904% |
Themis Medicare Limited | 705.74 Million INR | -844.524% |
RPG Life Sciences Limited | 1.01 Billion INR | -559.991% |
Zydus Lifesciences Limited | 34.41 Billion INR | 80.633% |
Lupin Limited | 49.53 Billion INR | 86.544% |
Amrutanjan Health Care Limited | 289.04 Million INR | -2206.168% |
Wockhardt Limited | 6.4 Billion INR | -4.155% |
Vaishali Pharma Limited | 3.79 Million INR | -175457.282% |
Aarti Pharmalabs Limited | 6.42 Billion INR | -3.691% |
Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -4344.829% |
Jubilant Pharmova Limited | 12.89 Billion INR | 48.31% |
FDC Limited | 3.88 Billion INR | -71.409% |
Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 89.511% |
Kilitch Drugs (India) Limited | 39.88 Million INR | -16614.92% |
Eris Lifesciences Limited | 1.89 Billion INR | -252.634% |
Venus Remedies Limited | 1.21 Billion INR | -447.778% |
ZIM Laboratories Limited | 812.62 Million INR | -720.289% |
Bliss GVS Pharma Limited | 1.18 Billion INR | -462.774% |
Par Drugs and Chemicals Limited | 41.77 Million INR | -15858.607% |
Caplin Point Laboratories Limited | 3.63 Billion INR | -83.614% |
Shilpa Medicare Limited | 3.44 Billion INR | -93.255% |
Albert David Limited | 436.12 Million INR | -1428.454% |
Ajanta Pharma Limited | 8.28 Billion INR | 19.529% |
Hester Biosciences Limited | 755.81 Million INR | -781.956% |
Suven Pharmaceuticals Limited | 2.31 Billion INR | -188.323% |
Solara Active Pharma Sciences Limited | 3.59 Billion INR | -85.319% |
Gufic Biosciences Limited | 2 Billion INR | -232.494% |
Windlas Biotech Limited | 621.89 Million INR | -971.879% |
Procter & Gamble Health Limited | 1.09 Billion INR | -510.935% |
Aarey Drugs & Pharmaceuticals Limited | 346.75 Million INR | -1822.356% |
Mangalam Drugs & Organics Limited | 1.23 Billion INR | -439.14% |
Granules India Limited | 13 Billion INR | 48.745% |
Aarti Drugs Limited | 4.85 Billion INR | -37.19% |
Bal Pharma Limited | 878.11 Million INR | -659.117% |
Alkem Laboratories Limited | 26.61 Billion INR | 74.951% |
Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 93.245% |
Lincoln Pharmaceuticals Limited | 771.68 Million INR | -763.817% |
Medicamen Biotech Limited | 593.75 Million INR | -1022.676% |
Unichem Laboratories Limited | 7.04 Billion INR | 5.405% |
Bafna Pharmaceuticals Limited | 296.41 Million INR | -2148.821% |
Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -26043.899% |
Valiant Laboratories Limited | 100.15 Million INR | -6555.66% |
Orchid Pharma Limited | 2.64 Billion INR | -152.281% |
Medico Remedies Limited | 163.37 Million INR | -3980.203% |
Ind-Swift Laboratories Limited | 104.57 Million INR | -6274.164% |
Ipca Laboratories Limited | 24.71 Billion INR | 73.027% |
Brooks Laboratories Limited | 96.1 Million INR | -6835.853% |
Syncom Formulations (India) Limited | 210.81 Million INR | -3061.971% |
Piramal Enterprises Limited | - INR | -Infinity% |
Torrent Pharmaceuticals Limited | 22.79 Billion INR | 70.751% |
NATCO Pharma Limited | 7 Billion INR | 4.841% |
Suven Life Sciences Limited | 7.08 Million INR | -93984.827% |
Krebs Biochemicals & Industries Limited | 97.96 Million INR | -6704.449% |
Strides Pharma Science Limited | 11.26 Billion INR | 40.813% |
Indoco Remedies Limited | 3.53 Billion INR | -88.804% |
Alpa Laboratories Limited | 136.65 Million INR | -4777.983% |
Lasa Supergenerics Limited | 190.43 Million INR | -3400.378% |
Sun Pharma Advanced Research Company Limited | 14.79 Million INR | -44964.292% |